Nishimura RA, Vahanian A, Eleid MF, Mack MJ. Mitral valve disease–current management and future challenges. Lancet. 2016;387(10025):1324–34. https://doi.org/10.1016/S0140-6736(16)00558-4.

Article  PubMed  Google Scholar 

Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study. Lancet. 2018;391:960–9. https://doi.org/10.1016/S0140-6736(18)30473-2.

Article  PubMed  PubMed Central  Google Scholar 

Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet. 2009;373:1382–94. https://doi.org/10.1016/S0140-6736(09)60692-9.

Article  PubMed  Google Scholar 

Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 1996;335:1417–23. https://doi.org/10.1056/NEJM199611073351902.

Article  CAS  PubMed  Google Scholar 

Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol. 2002;40:84–92. https://doi.org/10.1016/s0735-1097(02)01922-8.

Article  PubMed  Google Scholar 

Tribouilloy C, Rusinaru D, Grigioni F, et al. Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: a multicenter analysis. Circ Cardiovasc Imaging. 2014;7:363–70. https://doi.org/10.1161/CIRCIMAGING.113.001251.

Article  PubMed  Google Scholar 

Rossi A, Dini FL, Faggiano P, et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart. 2011;97:1675–80. https://doi.org/10.1136/hrt.2011.225789.

Article  PubMed  Google Scholar 

Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875–83. https://doi.org/10.1056/NEJMoa041451.

Article  CAS  PubMed  Google Scholar 

Filsoufi F, Carpentier A. Principles of reconstructive surgery in degenerative mitral valve disease. Semin Thorac Cardiovasc Surg. 2007;19:103–10. https://doi.org/10.1053/j.semtcvs.2007.04.003.

Article  PubMed  Google Scholar 

Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, Bonny A, Brauer M, Brodmann M, Cahill TJ, Carapetis J, Catapano AL, Chugh SS, Cooper LT, Coresh J, Criqui M, DeCleene N, Eagle KA, Emmons-Bell S, Feigin VL, Fernández-Solà J, Fowkes G, Gakidou E, Grundy SM, He FJ, Howard G, Hu F, Inker L, Karthikeyan G, Kassebaum N, Koroshetz W, Lavie C, Lloyd-Jones D, Lu HS, Mirijello A, Temesgen AM, Mokdad A, Moran AE, Muntner P, Narula J, Neal B, Ntsekhe M, Moraes de Oliveira G, Otto C, Owolabi M, Pratt M, Rajagopalan S, Reitsma M, Ribeiro ALP, Rigotti N, Rodgers A, Sable C, Shakil S, Sliwa-Hahnle K, Stark B, Sundström J, Timpel P, Tleyjeh IM, Valgimigli M, Vos T, Whelton PK, Yacoub M, Zuhlke L, Murray C, Fuster V; GBD-NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010. Erratum in: J Am Coll Cardiol. 2021 Apr 20;77(15):1958–1959. PMID: 33309175; PMCID: PMC7755038.

Han YC, Peters DC, Salton CJ, Bzymek D, Nezafat R, Goddu B, et al. Cardiovascular magnetic resonance characterization of mitral valve prolapse. JACC Cardiovasc Imaging. 2008;1:294–303. https://doi.org/10.1016/j.jcmg.2008.01.013.

Article  PubMed  Google Scholar 

Basso C, Perazzolo Marra M, Rizzo S, De Lazzari M, Giorgi B, Cipriani A, et al. Arrhythmic mitral valve prolapse and sudden cardiac death. Circulation. 2015;132:556–66. https://doi.org/10.1161/CIRCULATIONAHA.115.016291.

Article  PubMed  Google Scholar 

Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease The task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2017;38:2739. https://doi.org/10.1093/eurheartj/ehx391.

Article  PubMed  Google Scholar 

Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30:303–71. https://doi.org/10.1016/j.echo.2017.01.007.

Article  PubMed  Google Scholar 

Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O'Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C; ACC/AHA Joint Committee Members; O'Gara PT, Beckman JA, Levine GN, Al-Khatib SM, Armbruster A, Birtcher KK, Ciggaroa J, Deswal A, Dixon DL, Fleisher LA, de Las Fuentes L, Gentile F, Goldberger ZD, Gorenek B, Haynes N, Hernandez AF, Hlatky MA, Joglar JA, Jones WS, Marine JE, Mark D, Palaniappan L, Piano MR, Spatz ES, Tamis-Holland J, Wijeysundera DN, Woo YJ. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2021;162(2):e183–e353. https://doi.org/10.1016/j.jtcvs.2021.04.002.

Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J. 2004;25:1940–65. https://doi.org/10.1016/j.ehj.2004.06.040.

Article  PubMed  Google Scholar 

Masci PG, Dymarkowski S, Bogaert J. Valvular heart disease: what does cardiovascular MRI add? Eur Radiol. 2008;18:187–208. https://doi.org/10.1007/s00330-007-0731-x.

Article  Google Scholar 

Cawley PJ, Maki JH, Otto CM. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation. 2009;119:468–78. https://doi.org/10.1161/CIRCULATIONAHA.107.742486.

Article  PubMed  Google Scholar 

Nayak KS, Nielsen JF, Bernstein MA, et al. Cardiovascular magnetic resonance phase contrast imaging. J Cardiovasc Magn Reson. 2015;17:71. https://doi.org/10.1186/s12968-015-0172-7.

Article  PubMed  PubMed Central  Google Scholar 

Myerson SG, d’Arcy J, Christiansen JP, Dobson LE, Mohiaddin R, Francis JM, Prendergast B, Greenwood JP, Karamitsos TD, Neubauer S. Determination of Clinical Outcome in Mitral Regurgitation With Cardiovascular Magnetic Resonance Quantification. Circulation. 2016;133(23):2287–96. https://doi.org/10.1161/CIRCULATIONAHA.115.017888.

Article  PubMed  Google Scholar 

Buchner S, Debl K, Poschenrieder F, et al. Cardiovascular magnetic resonance for direct assessment of anatomic regurgitant orifice in mitral regurgitation. Circ Cardiovasc Imaging. 2008;1:148–55. https://doi.org/10.1161/CIRCIMAGING.107.753103.

Article  PubMed  Google Scholar 

Chan KMJ, Wage R, Symmonds K, Rahman-Haley S, Mohiaddin RH, Firmin DN, et al. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:61. https://doi.org/10.1186/1532-429X-10-61.

Article  PubMed  PubMed Central  Google Scholar 

Gabriel RS, Kerr AJ, Raffel OC, Stewart RA, Cowan BR, Occleshaw CJ. Mapping of mitral regurgitant defects by cardiovascular magnetic resonance in moderate or severe mitral regurgitation secondary to mitral valve prolapse. J Cardiovasc Magn Reson. 2008;10:16. https://doi.org/10.1186/1532-429X-10-16.

Article  PubMed  PubMed Central  Google Scholar 

Wolff R, Uretsky S. Defining the left ventricular base in mitral valve prolapse: impact on systolic function and regurgitation. Int J Cardiovasc Imaging. 2020;36:2221–7. https://doi.org/10.1007/s10554-020-01927-0.

Article  PubMed  Google Scholar 

Hudsmith LE, Petersen SE, Francis JM, Robson MD, Neubauer S. Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson. 2005;7:775–82. https://doi.org/10.1080/10976640500295516.

Article  PubMed  Google Scholar 

Penicka M, Vecera J, Mirica DC, Kotrc M, Kockova R, Van Camp G. Prognostic implications of magnetic resonance-derived quantification in asymptomatic patients with organic mitral regurgitation: comparison with Doppler echocardiography-derived integrative approach. Circulation. 2018;137:1349–60. https://doi.org/10.1161/CIRCULATIONAHA.117.029332.

Article  PubMed  Google Scholar 

Romero Daza A, Chokshi A, Pardo P, Maneiro N, Guijarro Contreras A, Larrañaga-Moreira JM, et al. Mitral valve prolapse morphofunctional features by cardiovascular magnetic resonance: more than just a valvular disease. J Cardiovasc Magn Reson. 2021;23:107. https://doi.org/10.1186/s12968-021-00800-w.

Article  PubMed  PubMed Central  Google Scholar 

Cameli M, Lisi M, Righini FM, Massoni A, Natali BM, Focardi M, et al. Usefulness of atrial deformation analysis to predict left atrial fibrosis and endocardial thickness in patients undergoing mitral valve operations for severe mitral regurgitation secondary to mitral valve prolapse. Am J Cardiol. 2013;111(4):595–601. https://doi.org/10.1016/j.amjcard.2012.10.049.

Article  PubMed  Google Scholar 

El-Tallawi KC, Kitkungvan D, Xu J, Cristini V, Yang EY, Quinones MA, et al. Resolving the disproportionate left ventricular enlargement in mitral valve prolapse due to barlow disease: insights from cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2021;14:573–84. https://doi.org/10.1016/j.jcmg.2020.08.029.

Article  PubMed  Google Scholar 

Levy F, Iacuzio L, Marechaux S, Civaia F, Dommerc C, Wautot F, et al. Influence of prolapse volume in mitral valve prolapse. Am J Cardiol. 2021;157:64–70. https://doi.org/10.1016/j.amjcard.2021.07.019.

Article  PubMed  Google Scholar 

Ahmed MI, Andrikopoulou E, Zheng J, Ulasova E, Pat B, Kelley EE, Powell PC, Denney TS Jr, Lewis C, Davies JE, Darley-Usmar V, Dell’Italia LJ. Interstitial Collagen Loss, Myocardial Remodeling, and Function in Primary Mitral Regurgitation. JACC Basic Transl Sci. 2022;7(10):973–81. https://doi.org/10.1016/j.jacbts.2022.04.014.

Article  PubMed  PubMed Central  Google Scholar 

Croisille P, Revel D, Saeed M. Contrast agents and cardiac MR imaging of myocardial ischemia: from bench to bedside. Eur Radiol. 2006;16:1951–63. https://doi.org/10.1007/s00330-006-0244-z.

Article  PubMed  Google Scholar 

Holtackers RJ, Van De Heyning CM, Chiribiri A, et al. Dark-blood late gadolinium enhancement cardiovascular magnetic resonance for improved detection of subendocardial scar: a review of current techniques. J Cardiovasc Magn Reson. 2021;23:96. https://doi.org/10.1186/s12968-021-00777-6.

Article  PubMed  PubMed Central  Google Scholar 

Van De Heyning CM, Holtackers RJ, Nazir MS, Grapsa J, Demetrescu C, Pype L, et al. Dark-blood late gadolinium enhancement CMR improves detection of papillary muscle fibrosis in patients with mitral valve prolapse. Eur J Radiol. 2022;147: 110118. https://doi.org/10.1016/j.ejrad.2021.110118.

Article  PubMed  Google Scholar 

Kim, et al. Flow-Independent Dark-blood DeLayed Enhancement (FIDDLE): validation of a novel black blood technique for the diagnosis of myocardial infarction. J Cardiovasc Magn Reson. 2016;18(Suppl 1). https://doi.org/10.1186/1532-429X-18-S1-O55.

•• Kitkungvan D, Nabi F, Kim RJ, Bonow RO, Khan MA, Xu J, et al. Myocardial fibrosis in patients with primary mitral regurgitation with and without prolapse. J Am Coll Cardiol. 2018;72:823–34. https://doi.org/10.1016/j.jacc.2018.06.048. Findings from this study showed higher prevale